Yoshida Yoichiro, Nagamori Tsunehisa, Ishibazawa Emi, Kobayashi Hiroya, Kure Tomoko, Sakai Hiromi, Takahashi Daisuke, Fujihara Mitsuhiro, Azuma Hiroshi
Department of Pediatrics, Asahikawa Medical University, Asahikawa, Japan.
Department of Immunopathology, Asahikawa Medical University, Asahikawa, Japan.
Immunopharmacol Immunotoxicol. 2020 Dec;42(6):614-624. doi: 10.1080/08923973.2020.1837866. Epub 2020 Nov 1.
Effects of liposomal particles on immune function have not been adequately investigated. Earlier reports indicate that intravenous injection of rats with pegylated liposomes comprising chemically defined specific lipids produces myeloid derived suppressor-cell (MDSC)-like cells in the spleen.
After liposome injection, we sought a cell surface marker expressed specifically on splenic macrophages. Then we assessed the immunosuppressive activity of macrophages positive for the marker. Furthermore, we investigated whether immunosuppression induction is an immunopharmacological action specific to this pegylated liposome, or not.
After using a microarray system to screen genes enhanced by this liposome, we evaluated cell surface expression of gene products using flow cytometry. Liposomes of several kinds, each comprising one type of phospholipid, were prepared and evaluated for their ability to induce T-cell suppression.
Microarray analysis indicated enhanced expression. Flow cytometry revealed that the B7-H3 molecule was expressed on splenic macrophages after liposome injection. B7-H3 macrophages were positive for iNOS. Removing B7-H3 cells restored T-cell proliferation. Similarly to this liposome, various liposomes with different long chain fatty acids induced T-cell suppression when accumulated in the spleen.
Immunosuppressive cells induced by this pegylated liposome closely resemble MDSCs, especially B7-H3 MDSCs. Immunosuppression induction is not a phenomenon specific to this liposome. Accumulation of long chain fatty acid in macrophages by internalization of liposomal nanoparticles might be related to macrophage acquisition of immunosuppressive activity .
脂质体颗粒对免疫功能的影响尚未得到充分研究。早期报告表明,给大鼠静脉注射包含化学定义的特定脂质的聚乙二醇化脂质体可在脾脏中产生髓源性抑制细胞(MDSC)样细胞。
在注射脂质体后,我们寻找在脾巨噬细胞上特异性表达的细胞表面标志物。然后我们评估了该标志物阳性的巨噬细胞的免疫抑制活性。此外,我们研究了免疫抑制诱导是否是这种聚乙二醇化脂质体特有的免疫药理作用。
在使用微阵列系统筛选受这种脂质体增强的基因后,我们使用流式细胞术评估基因产物的细胞表面表达。制备了几种分别包含一种磷脂的脂质体,并评估它们诱导T细胞抑制的能力。
微阵列分析表明表达增强。流式细胞术显示,注射脂质体后,B7-H3分子在脾巨噬细胞上表达。B7-H3巨噬细胞的诱导型一氧化氮合酶(iNOS)呈阳性。去除B7-H3细胞可恢复T细胞增殖。与这种脂质体类似,当各种含有不同长链脂肪酸的脂质体在脾脏中蓄积时,均可诱导T细胞抑制。
这种聚乙二醇化脂质体诱导的免疫抑制细胞与MDSC非常相似,尤其是B7-H3 MDSC。免疫抑制诱导并非这种脂质体特有的现象。脂质体纳米颗粒内化导致长链脂肪酸在巨噬细胞中的蓄积可能与巨噬细胞获得免疫抑制活性有关。